Dr. Olopade is a medical oncologist and Founder of the Clinical Cancer Genetics Program at the University of Chicago Medicine. She is an expert in cancer risk assessment and individualized treatment for the most aggressive forms of breast cancer, having developed novel management strategies based on an understanding of the altered genes in individual patients. She stresses comprehensive risk reducing strategies and prevention in high-risk populations, as well as earlier detection through advanced imaging technologies. Dr. Olopade has received numerous honors and awards, including honorary degrees from Princeton, Bowdoin, North Central, and Dominican universities. She is also a recipient of the MacArthur Foundation "Genius" Fellowship, and an American Cancer Society Clinical Research Professorship. She currently serves on the board of directors for the American Board of Internal Medicine, the National Cancer Advisory Board, Susan G. Komen for the Cure, Cancer IQ, and the Lyric Opera.